Summary
Pneumologie (onderdeel module inwendige aandoeningen) samenvatting
- Course
- Institution
Pneumologie, 1 van de 3 onderdelen van groter vak module inwendige aandoeningen. Samenvatting van lesnotities en lesslides.
[Show more]
Seller
Follow
lunagauchez
Content preview
PNEUMOLOGIEMODULE INWENDIGE AANDOENINGEN
INHOUDSOPGAVE
Semeiologie of the respiratory system ............................................................................................................. 4
1. Anamnese .................................................................................................................................................... 4
Cough .............................................................................................................................................................. 4
Haemoptysis .................................................................................................................................................... 6
Dyspnea ........................................................................................................................................................... 7
Thorax pain ..................................................................................................................................................... 8
2. Physical examination................................................................................................................................... 8
3. Complementary exams ................................................................................................................................ 9
Bronchoscopy .................................................................................................................................................. 9
Thoracoscopy .................................................................................................................................................. 9
Pleurocentesis ............................................................................................................................................... 10
Pulmonary function tests ............................................................................................................................... 11
Routine pulmonary function tests ..................................................................................................................... 11
Spirometry & flow-volume loop .................................................................................................................... 11
Pulmonary volumes → TLC, FRC, RV ................................................................................................................. 16
Pulmonary volumes....................................................................................................................................... 16
Pulmonary diffusion capacity → DLCO, KCO ..................................................................................................... 17
Pulmonary diffusion capacity (DLCO) ............................................................................................................ 17
Summary classification of lung defects ............................................................................................................. 18
Pneumologie in practice ................................................................................................................................. 19
Casus 1 .............................................................................................................................................................. 19
COPD: Chronic obstructive pulmonary disease............................................................................................. 19
CASUS 2 ............................................................................................................................................................. 25
Astma ............................................................................................................................................................ 25
Cystic fibrosis (CF) ......................................................................................................................................... 29
Casus 3 .............................................................................................................................................................. 32
Pneumonie .................................................................................................................................................... 32
Micro-organismen ......................................................................................................................................... 35
Necrotiserende pneumonie .......................................................................................................................... 36
Longabces...................................................................................................................................................... 36
Tuberculose ................................................................................................................................................... 36
, COVID-19 ....................................................................................................................................................... 37
Pleurale effusie ............................................................................................................................................. 40
Atelectase...................................................................................................................................................... 42
Hemopteu ..................................................................................................................................................... 42
Neuromusculair lijden ................................................................................................................................... 44
CONCLUSIE ........................................................................................................................................................ 44
Inhalation therapy ......................................................................................................................................... 46
The triangle of good inhalation ......................................................................................................................... 46
Drugs used for inhalation .................................................................................................................................. 46
Correct inhalation.............................................................................................................................................. 47
Incorrect inhalation ........................................................................................................................................... 47
Factors affecting deposition .............................................................................................................................. 48
Available inhalation devices .............................................................................................................................. 48
Improve the coordination problems of a pMDI ................................................................................................. 51
Spacers for pMDI: different types ................................................................................................................. 51
Nebulizers: indications for use are limited ........................................................................................................ 51
Inhalers .............................................................................................................................................................. 52
Choice of inhaler based on the patient in front of you ...................................................................................... 52
Inspiratory capactity – can my patients use DPI? In check dial..................................................................... 53
Instructions on inhalators.................................................................................................................................. 53
Acute and chronic respiratory insufficiency/failure ........................................................................................ 54
Respiratory failure ............................................................................................................................................. 54
Performing an arterial blood gass analysis ................................................................................................... 54
Normal values ............................................................................................................................................... 54
Classification of respiratory failure ................................................................................................................... 55
RIS type 2 – ventilatory (pump) failure – causes ........................................................................................... 56
Multimodaltity therapy in chronic respiratory failure .................................................................................... 57
Effects of multimodality therapy of cris ............................................................................................................ 57
Smoking cessation ............................................................................................................................................. 57
Pulmonary rehabilitation: rationale .................................................................................................................. 58
Pulmonary rehabilitation in COPD ................................................................................................................ 58
Oxygen therapy in chronic respiratory failure ................................................................................................ 59
Oxygen therapy reimbursement criteria ........................................................................................................... 59
In hospital oxygen ............................................................................................................................................. 59
At home oxygen source ..................................................................................................................................... 59
Oxygen sypply systems ...................................................................................................................................... 60
Nasal cannula ................................................................................................................................................ 60
, Nasopharyngeal oxygen catheder ................................................................................................................. 60
Oxygen mask ................................................................................................................................................. 60
Oxygen mask with bag .................................................................................................................................. 61
High flow oxygen mask ................................................................................................................................. 61
High flow nasal oxygen ‘Optiflow’ ................................................................................................................. 61
Cardiopulmonary Excercise testing (CPET) ..................................................................................................... 62
Ergospirometry .................................................................................................................................................. 62
CPET ‘machine’: cycle-ergometer or treadmill ergometer/electrocardiograph ........................................... 62
Cardiopulmonary exercise training ................................................................................................................... 62
Indications for CPET........................................................................................................................................... 63
Bio-energetic basis of work performance.......................................................................................................... 63
Measurements: breath-by-breath gas analyser/pneumotachograph/oximeter............................................... 64
Comprehensive cardiopulminary exercise testing (CPET) .................................................................................. 65
Measurements during CPET .......................................................................................................................... 65
Wich protocol, wich modality? ..................................................................................................................... 66
Physiology of Exercise ....................................................................................................................................... 66
Typical cardiopulmonary responses to exercise ........................................................................................... 67
Ventilatory response ..................................................................................................................................... 68
Cardiac responses ......................................................................................................................................... 74
Patterns of exercise responses ..................................................................................................................... 75
Take home messages ........................................................................................................................................ 80
, SEMEIOLOGIE OF THE RESPIRATORY SYSTEM
1. ANAMNESE
• Cough
o Dry
o Productive: sputum production (or expectoration)
• Haemoptysis
o = ophoesten van bloed
• Dyspnea
o = kortademigheid
• Thorax pain
COUGH
• Classification
o Acute (< 3 weeks)
o Subacute (3-8 weeks)
o Chronic (> 8 weeks)
• Epidemiology
o Up to 40 % of ambulatory consults
o 75-90 % identifiable cause
o 95 % successful treatment possible
• Dry
• Productive
• Aspect/color:
o Aquous
o Mucus of mucopurulent
▪ = etterig
o Purulent
o Blood = hemoptysis
• Smell: putrid: anaerobic: lung abscess
• Bronchorrhea (excessive sputum): bronchiectasis, lung abscess, broncho-alveolar cell carcinoma,
Cystic Fibrosis
o = MUCO
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller lunagauchez. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $6.34. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
51036 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy study notes for 15 years now